Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-27 @ 2:31 AM
Study NCT ID:
NCT00520494
Status:
COMPLETED
Last Update Posted:
2013-06-20
First Post:
2007-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
Sponsor:
CSL Behring
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Previously Untreated Patient (PUP) | View |
| None | Primary Immunodeficiency (PID) | View |
| None | CVID | View |
| None | XLA | View |
| None | Subcutaneous immunoglobulin (SCIG) | View |
| None | IgG trough level | View |
| None | Quality of life | View |
| None | Common variable immunodeficiency (CVID) | View |
| None | X-linked agammaglobulinemia (XLA) | View |